BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21836637)

  • 1. The transcription factor Krox20 is an E3 ligase that sumoylates its Nab coregulators.
    García-Gutiérrez P; Juárez-Vicente F; Gallardo-Chamizo F; Charnay P; García-Domínguez M
    EMBO Rep; 2011 Sep; 12(10):1018-23. PubMed ID: 21836637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO E3 ligase activity of TRIM proteins.
    Chu Y; Yang X
    Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.
    Ivanov AV; Peng H; Yurchenko V; Yap KL; Negorev DG; Schultz DC; Psulkowski E; Fredericks WJ; White DE; Maul GG; Sadofsky MJ; Zhou MM; Rauscher FJ
    Mol Cell; 2007 Dec; 28(5):823-37. PubMed ID: 18082607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.
    Chang PC; Izumiya Y; Wu CY; Fitzgerald LD; Campbell M; Ellison TJ; Lam KS; Luciw PA; Kung HJ
    J Biol Chem; 2010 Feb; 285(8):5266-73. PubMed ID: 20034935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanistic view of the role of E3 in sumoylation.
    Tozluoğlu M; Karaca E; Nussinov R; Haliloğlu T
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20865051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y; Chung KC
    J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
    Sáez JE; Arredondo C; Rivera C; Andrés ME
    Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SLX4 complex is a SUMO E3 ligase that impacts on replication stress outcome and genome stability.
    Guervilly JH; Takedachi A; Naim V; Scaglione S; Chawhan C; Lovera Y; Despras E; Kuraoka I; Kannouche P; Rosselli F; Gaillard PHL
    Mol Cell; 2015 Jan; 57(1):123-37. PubMed ID: 25533188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
    Sohn SY; Hearing P
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH; Melhuish TA; Wotton D
    Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.
    Liang Q; Deng H; Li X; Wu X; Tang Q; Chang TH; Peng H; Rauscher FJ; Ozato K; Zhu F
    J Immunol; 2011 Nov; 187(9):4754-63. PubMed ID: 21940674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
    J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.